Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
MoonLake Immunotherapeutics
NASDAQ:MLTX
Price:
11.78
USD
-6.28%
Market Cap:
$973.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
CH |
|
Granges AB
F:9GR
|
SE |
|
Great Southern Bancorp Inc
NASDAQ:GSBC
|
US |
|
A
|
ABO Energy GmbH & Co KgaA
XHAM:AB9
|
DE |
|
A
|
Altria Group Inc
BMV:MO
|
US |
|
Concurrent Technologies PLC
LSE:CNC
|
UK |
|
International Parkside Products Inc
XTSX:IPD
|
CA |
|
M
|
Montana Aerospace AG
SIX:AERO
|
CH |
|
J
|
JLK Inc
KOSDAQ:322510
|
KR |
|
Q
|
Quanta Computer Inc
OTC:QUCCF
|
TW |
Wall St Price Targets
MLTX Price Forecast
Based on 16 analysts
Based on 16 analysts
+160% Upside
from
$11.78
today
MoonLake Immunotherapeutics (MLTX)’s 12-month stock price forecast through October 2027 has a consensus target of $30.6, implying 160% upside. The forecast is based on price targets from 16 Wall Street analysts.
MoonLake Immunotherapeutics Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MLTX's stock price target?
Price Target
30.6
USD
30.6
USD
According to Wall Street analysts, the average 1-year price target for MLTX is 30.6 USD with a low forecast of 6.06 USD and a high forecast of 73.5 USD.